16705029

Source:http://linkedlifedata.com/resource/pubmed/id/16705029

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036992, umls-concept:C0087111, umls-concept:C1530889
pubmed:issue	6
pubmed:dateCreated	2006-6-7
pubmed:abstractText	To summarize the pharmacology, development, and clinical application of teduglutide (ALX-0600), a glucagon-like peptide-2 (GLP-2) analog for the treatment of short bowel syndrome (SBS).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9203131
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/teduglutide
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1060-0280
pubmed:author	pubmed-author:FerroneMarcusM, pubmed-author:ScolapioJames SJS
pubmed:issnType	Print
pubmed:volume	40
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1105-9
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:16705029-Animals, pubmed-meshheading:16705029-Clinical Trials as Topic, pubmed-meshheading:16705029-Humans, pubmed-meshheading:16705029-Peptides, pubmed-meshheading:16705029-Short Bowel Syndrome
pubmed:year	2006
pubmed:articleTitle	Teduglutide for the treatment of short bowel syndrome.
pubmed:affiliation	Department of Pharmacy; Nutrition Mayo Clinic/St. Luke's Hospital, Jacksonville, FL 32216, USA. ferrone.marcus@mayo.edu
pubmed:publicationType	Journal Article, Review